bg
B

Bioatla (BCAB)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Bioatla (BCAB)

BioAtla, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing our novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.

  • USD1.73
  • USD1.79
  • USD1.71
  • USD11.73
  • -29.20%
  • --
  • 119.07k
  • 262.45k
  • 86M
  • 1.67
  • -78.50%

Unlock More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.